mannitol has been researched along with avapro in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bansal, AK; Chawla, G | 1 |
| Bowen, W; Ghosh, I; Karki, S; Kumar, S; Meruva, S; Shah, S; Thool, P | 1 |
| Bowen, W; Ghosh, I; Karki, S; Kumar, S; Meruva, S; Thool, P | 1 |
1 review(s) available for mannitol and avapro
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for mannitol and avapro
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives.
Topics: Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallography, X-Ray; Excipients; Hypromellose Derivatives; Irbesartan; Kinetics; Mannitol; Methylcellulose; Microscopy; Models, Chemical; Povidone; Powder Diffraction; Solubility; Tartrates; Technology, Pharmaceutical; Tetrazoles; Transition Temperature | 2008 |
Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.
Topics: Antihypertensive Agents; Cellulose; Desiccation; Drug Compounding; Drug Liberation; Drug Stability; Irbesartan; Mannitol; Nanoparticles; Particle Size; Powders | 2019 |
Downstream processing of irbesartan nanocrystalline suspension and mini-tablet development - Part II.
Topics: Antihypertensive Agents; Cellulose; Desiccation; Drug Compounding; Drug Liberation; Drug Stability; Irbesartan; Mannitol; Nanoparticles; Suspensions; Tablets | 2019 |